Search company, investor...

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year



Debt | Dead

Total Raised


Last Raised


About IntelliGene

Developer of a platform technology for molecular recognition and detection. The technology is based on ribozymes, nano-machines that facilitate a new mode of biomolecular recognition and signal amplification, and which can be inserted into cells using traditional vectors, in order to track a cell's metabolism while inside the cell and in vivo. The platform can recognize small molecules, proteins and nucleic acids, and the technology can also be applied to a standard DNA chip so that it can detect a wide range of biomolecules.

IntelliGene Headquarters Location

Am Veolamo Street P.O. Box 35241

Givat Shaul, 91351,


972 2 6540333

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

  • When was IntelliGene founded?

    IntelliGene was founded in 1993.

  • Where is IntelliGene's headquarters?

    IntelliGene's headquarters is located at Am Veolamo Street, Givat Shaul.

  • What is IntelliGene's latest funding round?

    IntelliGene's latest funding round is Debt.

  • How much did IntelliGene raise?

    IntelliGene raised a total of $11.6M.

  • Who are the investors of IntelliGene?

    Investors of IntelliGene include Kreos Capital, Medmax Ventures, Gemini Israel Ventures, Pitango Venture Capital, Walden Israel Venture Capital and 4 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.